Pain, Anxiety Represent Barriers to Anti-VEGF Therapies for Costly Eye Conditions
November 17th 2021Pain and fear/anxiety were the most common barriers to anti–vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration and diabetic macular edema. Another study found that those conditions had a significant impact on patients’ quality of life and Medicare costs.
Read More
Posters Provide Evidence on COPD Treatment Considerations, Exacerbation Risk Assessment
November 16th 2021Chronic obstructive pulmonary disease (COPD) management should take into account patients’ comorbidities, according to a poster presented at the Academy of Managed Care Pharmacy Nexus 2021 meeting. Another poster validated the use of the COPD Treatment Ratio as a measure of exacerbation risk.
Read More
Study Identifies Alcohol Use as Potential Risk Factor for AMD Subtype
November 15th 2021A new study provides genetic evidence that increased alcohol intake may be a causal risk factor for geographic atrophy, a type of advanced age-related macular degeneration (AMD), but doctors caution it may be too soon to advise patients about the risk.
Read More
Study Demonstrates Benefits of Community Participation in Patients With COPD
November 5th 2021Community participation by individuals with chronic obstructive pulmonary disease (COPD) resulted in better lung function, improved exercise capacity, and less breathlessness, according to a recent study.
Read More